Venmax Drugs and Pharmaceuticals Limited (BSE: 531015)
Health Care · Pharmaceuticals · IN
Rs16.93
-1.57% today · -40.2% 1Y
Venmax Drugs and Pharmaceuticals Limited (BSE: 531015) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.05M.
Over the last twelve months the share price has lost 40.2%, trading between 15.56 and 36.96.
Tweenvest scores Venmax Drugs and Pharmaceuticals Limited across four factors: quality 39/100, value 40/100. Its strongest factor is value.
531015 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.05M
- Revenue (TTM)
- $982.95K
- P/E
- 69.28
- EPS
- 0.24
- Dividend yield
- —
- Beta (5Y)
- -1.73
- 52-week high
- Rs36.96
- 52-week low
- Rs15.56
- Avg volume (3M)
- —
- Shares outstanding
- 11.58M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,194.97 | -3.14% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $269.67 | -1.27% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.19 | -2.08% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.29 | -0.98% |
Figures last refreshed Aug 18, 2026.